Listed

Sarepta Therapeutics, Inc.

SRPTNasdaqCIK 873303HealthcareFiscal year ends Dec 31

Reports and events: 348 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Sarepta Therapeutics, Inc., Reports and events
FiledFormWhat it isAccession number
2023-03-0307:31 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001193125-23-058990
2023-02-2816:04 ET10-KAnnual reportPeriod 2022-12-310000950170-23-005062
2023-01-0913:40 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-23-000495
2022-12-1317:11 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001193125-22-303900
2022-11-0217:00 ET8-K5.02 Departure or appointment of officers or directors0001193125-22-275897
2022-11-0216:04 ET10-QQuarterly reportPeriod 2022-09-300000950170-22-021213
2022-09-1916:31 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-247130
2022-08-0216:03 ET10-QQuarterly reportPeriod 2022-06-300000950170-22-013863
2022-06-0316:20 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0000950170-22-011164
2022-05-0416:05 ET10-QQuarterly reportPeriod 2022-03-310000950170-22-007375
2022-04-2516:19 ETDEF 14AProxy statementPeriod 2022-06-020001564590-22-015429
2022-04-2108:00 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-22-112139
2022-04-0520:26 ET8-K5.02 Departure or appointment of officers or directors0000950170-22-005381
2022-03-0116:03 ET10-KAnnual reportPeriod 2021-12-310000950170-22-002517
2022-01-1010:53 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-22-000205
2021-11-1708:34 ET8-K5.02 Departure or appointment of officers or directors0000950170-21-004713
2021-11-0316:04 ET10-QQuarterly reportPeriod 2021-09-300000950170-21-002815
2021-10-1516:17 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-300047
2021-09-2708:34 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-21-048961
2021-08-0416:03 ET10-QQuarterly reportPeriod 2021-06-300001564590-21-040787
2021-06-0317:00 ET8-K5.07 Shareholder vote results0001564590-21-031601
2021-05-1808:57 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-21-028550
2021-05-0516:02 ET10-QQuarterly reportPeriod 2021-03-310001564590-21-024018
2021-05-0308:52 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-21-022707
2021-04-2016:10 ETDEF 14AProxy statementPeriod 2021-06-030001564590-21-019631
2021-03-0116:02 ET10-KAnnual reportPeriod 2020-12-310001564590-21-009835
2021-01-1110:32 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-21-000783
2021-01-0717:03 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-21-000577
2020-12-1408:55 ET8-K5.02 Departure or appointment of officers or directors0001564590-20-056951
2020-11-0516:09 ET10-QQuarterly reportPeriod 2020-09-300001564590-20-051308
2020-09-2517:06 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation0001564590-20-044684
2020-09-0917:22 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-20-043013
2020-08-0516:06 ET10-QQuarterly reportPeriod 2020-06-300001564590-20-036794
2020-08-0516:01 ET8-K5.02 Departure or appointment of officers or directors0001564590-20-036775
2020-06-3008:40 ET8-K5.02 Departure or appointment of officers or directors0001564590-20-031151
2020-06-0809:18 ET8-K5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001564590-20-028562
2020-06-0809:05 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-20-028560
2020-05-0616:02 ET10-QQuarterly reportPeriod 2020-03-310001564590-20-021905
2020-04-2116:19 ETDEF 14AProxy statementPeriod 2020-06-040001564590-20-017698
2020-03-1916:28 ET8-K5.02 Departure or appointment of officers or directors0001564590-20-011806
2020-02-2616:04 ET10-KAnnual reportPeriod 2019-12-310001564590-20-006769
2020-02-2116:38 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001564590-20-005773
2020-02-1808:30 ET8-K8.01 Other events0001564590-20-004916
2020-01-1312:31 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-20-000941
2020-01-1308:41 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001564590-20-000918
2019-12-2316:01 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity0001564590-19-046705
2019-12-1316:01 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events0001564590-19-045957
2019-11-0716:03 ET10-QQuarterly reportPeriod 2019-09-300001564590-19-041709
2019-10-0408:40 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-19-036441
2019-08-2018:29 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-19-032588

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 19:58 ET. Listed shows no prices and gives no investment advice.